CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   OTHER
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Roche buys U.S. biotech Jecure in race for liver disease drugs
11-27-2018
REFILE-Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
11-26-2018
Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
11-26-2018
In half of hepatitis C patients, DAA treatment can shortened to 6 weeks
11-23-2018
Screening, brief behavioral counseling can reduce unhealthy alcohol use
11-13-2018
View Complete News Library
 
 
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Treatment of NASH with Gastric Bypass
 
Tie-ing up angiogenesis to treat NASH
 
Relationship Between Three Commonly Used Non-invasive Fibrosis Biomarkers and Improvement in Fibrosis Stage in Patients With NASH
 
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico
 
Hepatitis B Prevalence and Risk Factors in a Foreign-Born Asian and Pacific Islander Population at a Community Health Center in Hawai'i
 
Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
 
A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease
 
The impact of currently licensed therapies on viral and immune responses in Chronic Hepatitis B: considerations for future novel therapeutics
 
Lichen striatus-like eruption in an adult following hepatitis B vaccination: a case report and review of the literature
 
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
 
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)
 
Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/Sofosbuvir
 
 
Elimination of Hepatitis C in Liver Transplant Recipients
 
Differences in Referral Access to Care Between Gastrointestinal Subspecialty Patients: Barriers and Opportunities
 
Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
 
Impact of all-oral direct-acting antivirals on clinical and economic outcomes in chronic hepatitis C patients in the U.S
 
Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus
 
Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine
 
Funding Hepatitis C Treatment in Correctional Facilities by Using a Nominal Pricing Mechanism
 
Review article: novel antivirals for hepatitis C-sofosbuvir/velpatasvir/voxilaprevir, glecaprevir/pibrentasvir
 
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies
 
Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques
 
Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy-A Meta-Analysis
 
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
 
 
Periodontal Therapy Favorably Modulates the Oral-Gut-Hepatic Axis in Cirrhosis
 
Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA
 
Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging
 
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
 
The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD
 
Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
 
Chronic Kidney Disease is Independently Associated with Increased Mortality in Patients with Non-alcoholic Fatty Liver Disease
 
Advances in Pediatric Fatty Liver Disease: Pathogenesis, Diagnosis, and Treatment
 
NAFLD and liver transplantation in children - Working group report from the ILTS single topic conference on NAFLD
 
Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease with Insights from Humans and Animals: Pediatric Implications
 
Longitudinal analysis of risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in adulthood
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.